AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Wealth building requires strategic financial planning. Explore various strategies to effectively grow your wealth.
22,186 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Tokyo police have detained a senior figure tied to the Prince Group in a luxury Osaka hotel raid, tying him to a spra...
Prediction markets are soaring as the 2026 World Cup kicks into high gear, with multi-billion volumes on Kalshi, Poly...
A Portland, Oregon court filing shows Compass has settled the Murch TCPA lawsuit. The terms are confidential, and a n...
Super Micro Computer's stock has swung wildly in the AI era. This guide explains what the current valuation means, ho...
Three candidates backed by mayor zohran mamdani ‘better won key NYC primaries, expanding the left-leaning bloc and si...
The Justice Department announced a multi-state PFAS settlement with Chemours, totaling about $450 million in penaltie...
FuelCell Energy leads a sell-off in fuel-cell stocks as investors lock in gains after a sharp rally, while Bloom Ener...
As AI accelerates, data centers and their support systems become the real backbone of growth. This article breaks dow...
The U.S. launches an aircraft strike on Iran after a drone attack on a cargo ship near Hormuz, triggering market vola...
A pipeline-focused ETF is drawing retirees with its steady monthly payouts, delivering roughly 7.8% annual yield and ...
When a tech stock dives 84%, it can feel like a lost cause. This guide shows a disciplined way to assess beaten-down ...